Unknown

Dataset Information

0

Alveolar Macrophages Treated With Bacillus subtilis Spore Protect Mice Infected With Respiratory Syncytial Virus A2.


ABSTRACT: Respiratory syncytial virus (RSV) is a major pathogen that infects lower respiratory tract and causes a common respiratory disease. Despite serious pathological consequences with this virus, effective treatments for controlling RSV infection remain unsolved, along with poor innate immune responses induced at the initial stage of RSV infection. Such a poor innate defense mechanism against RSV leads us to study the role of alveolar macrophage (AM) that is one of the primary innate immune cell types in the respiratory tract and may contribute to protective responses against RSV infection. As an effective strategy for enhancing anti-viral function of AM, this study suggests the intranasal administration of Bacillus subtilis spore which induces expansion of AM in the lung with activation and enhanced production of inflammatory cytokines along with several genes associated with M1 macrophage differentiation. Such effect by spore on AM was largely dependent on TLR-MyD88 signaling and, most importantly, resulted in a profound reduction of viral titers and pathological lung injury upon RSV infection. Taken together, our results suggest a protective role of AM in RSV infection and its functional modulation by B. subtilis spore, which may be a useful and potential therapeutic approach against RSV.

SUBMITTER: Hong JE 

PROVIDER: S-EPMC6423497 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alveolar Macrophages Treated With <i>Bacillus subtilis</i> Spore Protect Mice Infected With Respiratory Syncytial Virus A2.

Hong Ji Eun JE   Kye Yoon-Chul YC   Park Sung-Moo SM   Cheon In Su IS   Chu Hyuk H   Park Byung-Chul BC   Park Yeong-Min YM   Chang Jun J   Cho Jae-Ho JH   Song Man Ki MK   Han Seung Hyun SH   Yun Cheol-Heui CH  

Frontiers in microbiology 20190312


Respiratory syncytial virus (RSV) is a major pathogen that infects lower respiratory tract and causes a common respiratory disease. Despite serious pathological consequences with this virus, effective treatments for controlling RSV infection remain unsolved, along with poor innate immune responses induced at the initial stage of RSV infection. Such a poor innate defense mechanism against RSV leads us to study the role of alveolar macrophage (AM) that is one of the primary innate immune cell type  ...[more]

Similar Datasets

| S-EPMC6399134 | biostudies-literature
| S-EPMC7911427 | biostudies-literature
2018-03-08 | GSE108659 | GEO
| S-EPMC6182894 | biostudies-literature
| S-EPMC4015724 | biostudies-literature
| S-EPMC3256263 | biostudies-other
| S-EPMC2687167 | biostudies-literature
| S-EPMC101994 | biostudies-literature
| S-EPMC6417949 | biostudies-literature
| S-EPMC7821199 | biostudies-literature